FDA Guidance Update on Peptide API Manufacturing — Key Takeaways

The FDA has released updated guidance on peptide API manufacturing under 21 CFR Part 211, with new requirements for impurity profiling and process validation. keruihk's QA team has reviewed the guidance and confirmed full compliance. We summarize the key changes and their impact on peptide manufacturers.

← Back to News
Newsletter

Stay Ahead in
Peptide Science

Join 5,000+ pharmaceutical and biotech professionals who receive our monthly newsletter — covering product launches, regulatory updates, and industry insights.

  • New product launches & catalog updates
  • Regulatory news & compliance updates
  • Industry trends & market insights
  • Company milestones & partnerships

Subscribe to Our Newsletter

Monthly digest, no spam. Unsubscribe anytime.

By subscribing, you agree to our Privacy Policy. No spam, ever.